Gene therapy has been administered at Amrita Hospital, Kochi, to Mia Maria, who was diagnosed with the rare genetic disorder Spinal Muscular Atrophy (SMA) Type 1. The gene therapy marks a crucial milestone in Mia’s treatment, following the successful mobilisation of ₹16.5 crore within three days through public support.
Mia had been undergoing treatment at Amrita Hospital after being diagnosed with SMA Type 1. The gene therapy was administered to help prevent the progression of the disease. Her treatment and ongoing care are being carried out under the supervision of a multidisciplinary medical team led by Dr. Vinayan K.P., Head of the Department of Paediatric Neurology, Amrita Hospital; Dr. Rashmi Ravindran, Assistant Professor; and Dr. Sajith Kesavan, Head of the Department of Paediatric Pulmonary.
After Mia’s family sought public support to raise the substantial amount required for her treatment, thousands of people from Kerala and beyond came forward to extend their help. Contributions ranging from small donations to substantial financial support enabled the family to raise ₹16.5 crore within just three days, reflecting the collective compassion and support of the people of Kerala.
Following the gene therapy, Mia’s health condition and response to the treatment will be closely monitored by the medical team. Her continued care, including further treatment and rehabilitation, will remain under the supervision of the specialist team.
Mia’s family expressed their gratitude to the thousands of well-wishers, members of the public and the media who supported her treatment and stood by the family during this journey.
